Sort
15,842 grants matching “pancreatic cancer”
Tissue Core
$238,905Julia Bridge · University Of Nebraska Medical Center · P50 · FY2016 · CA
Tissue Core
$238,905Julia Bridge · University Of Nebraska Medical Center · P50 · FY2014 · CA
Bioinformatics Shared Resource
$238,833Jean-Pierre A Kocher · Mayo Clinic Rochester · P30 · FY2019 · CA
The SMYD3-ERK5 signaling module in pancreatic cancer
$238,818Pawel K. Mazur · University Of Tx Md Anderson Can Ctr · R00 · FY2019 · CA
Antibody bead array technology for diagnosis of pre-invasive pancreatic cancer
$238,685Peter J Allen · Sloan-Kettering Inst Can Research · R21 · FY2012 · CA
Mesothelin as a biomarker for clinical management of esophageal adenocarcinoma
$238,685Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R21 · FY2012 · CA
Regulation of ErbB4 Signaling by Neuregulin Isoforms
$238,664David J. Riese · Purdue University · R01 · FY2009 · CA
Clinical Research Core
$238,658Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2017 · CA
Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis
$238,625Ly James Lee · Nanomaterial Innovation, Ltd · R43 · FY2018 · CA
Regulation of ErbB4 Signaling by Neuregulin Isoforms
$238,603David J. Riese · Purdue University · R01 · FY2008 · CA
Regulation of B1 Integrin Glycosylation by RAS
$238,569University Of Alabama At Birmingham · R01 · FY2004 · CA
Regulation of B1 Integrin Glycosylation by RAS
$238,569University Of Alabama At Birmingham · R01 · FY2003 · CA
Regulation of B1 Integrin Glycosylation by RAS
$238,569University Of Alabama At Birmingham · R01 · FY2005 · CA
Regulation of ErbB4 Signaling by Neuregulin Isoforms
$238,542David J. Riese · Purdue University · R01 · FY2007 · CA
Repurposing Bazedoxifene for chemoprevention in pre-invasive pancreatic cancer IPMN
$238,542Christine Iok In Chio · Columbia University Health Sciences · R21 · FY2022 · CA
Microenvironmental Transport for Immunotherapy in Pancreatic Cancer
$238,528Jason B Fleming · Methodist Hospital Research Institute · U54 · FY2018 · CA
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
$238,500Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2016 · CA
IL-10/IL10R in the Regulation of Self-Reactive CTL by CD8+ T-cells
$238,500Larry R Pease · Mayo Clinic Rochester · R21 · FY2017 · AI
First in Human Trials of ProAgio, a Cytotoxin
$238,460Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
THE INFLAMMATORY RESPONSE OF THE PANCREATIC ACINAR CELL
$238,438University Of California Los Angeles · R01 · FY2002 · DK
Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents
$238,369Juan Enrique Rozengurt · University Of California Los Angeles · P01 · FY2022 · CA
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
$238,368Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2022 · CA
CC: Clinical Research
$238,263Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2009 · CA
Cellular Interactions between TGF-B Pathway Members and TERT and c-Myc in Gastroi
$238,257Bibhuti B Mishra · Georgetown University · P01 · FY2009 · CA
Administrative Core
$238,183Dean E. Brenner · University Of Michigan At Ann Arbor · P50 · FY2010 · CA